A detailed history of Jpmorgan Chase & CO transactions in Novartis Ag stock. As of the latest transaction made, Jpmorgan Chase & CO holds 312,076 shares of NVS stock, worth $30.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
312,076
Previous 317,814 1.81%
Holding current value
$30.7 Million
Previous $33.8 Million 6.09%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$106.13 - $120.89 $608,973 - $693,666
-5,738 Reduced 1.81%
312,076 $35.9 Million
Q2 2024

Aug 12, 2024

SELL
$92.57 - $107.37 $8.06 Million - $9.34 Million
-87,017 Reduced 21.49%
317,814 $33.8 Million
Q1 2024

May 10, 2024

BUY
$95.27 - $108.47 $5.18 Million - $5.9 Million
54,370 Added 15.51%
404,831 $39.2 Million
Q4 2023

Feb 12, 2024

SELL
$92.27 - $101.54 $870,844 - $958,334
-9,438 Reduced 2.62%
350,461 $35.4 Million
Q3 2023

Nov 14, 2023

SELL
$94.73 - $105.13 $2.57 Million - $2.85 Million
-27,138 Reduced 7.01%
359,899 $36.7 Million
Q2 2023

Aug 11, 2023

SELL
$92.52 - $104.91 $2.22 Million - $2.52 Million
-24,038 Reduced 5.85%
387,037 $39.1 Million
Q1 2023

May 11, 2023

SELL
$80.03 - $92.81 $1.97 Million - $2.29 Million
-24,656 Reduced 5.66%
411,075 $37.8 Million
Q4 2022

Feb 13, 2023

SELL
$75.55 - $92.52 $8.39 Million - $10.3 Million
-111,014 Reduced 20.3%
435,731 $39.5 Million
Q3 2022

Nov 14, 2022

SELL
$74.61 - $87.26 $8.67 Million - $10.1 Million
-116,250 Reduced 17.53%
546,745 $41.6 Million
Q2 2022

Aug 11, 2022

BUY
$80.52 - $93.75 $35.8 Million - $41.7 Million
444,401 Added 203.3%
662,995 $56 Million
Q1 2022

May 11, 2022

SELL
$80.11 - $90.62 $3.99 Million - $4.51 Million
-49,776 Reduced 18.55%
218,594 $19.2 Million
Q4 2021

Feb 10, 2022

SELL
$79.7 - $88.13 $3.04 Million - $3.36 Million
-38,165 Reduced 12.45%
268,370 $23.5 Million
Q3 2021

Nov 12, 2021

BUY
$81.78 - $95.14 $25.1 Million - $29.2 Million
306,535 New
306,535 $25.1 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.